M J van de Vijver Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

11/2018

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M J van de Vijver Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2000
13	Neoplasms (Cancer) 04/2022 - 03/2000
3	Neoplasm Metastasis (Metastasis) 04/2019 - 04/2001
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2008 - 02/2001
2	Carcinoma (Carcinomatosis) 01/2014 - 04/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018
1	Polyps 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Ovarian Epithelial Carcinoma 01/2014
1	Triple Negative Breast Neoplasms 04/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009
1	Esophageal Neoplasms (Esophageal Cancer) 12/2009
1	Lymphatic Metastasis 04/2006
1	Osteosarcoma (Osteogenic Sarcoma) 05/2004
1	Ductal Carcinoma 02/2001

Drug/Important Bio-Agent (IBA)

5	Estrogen ReceptorsIBA 04/2022 - 03/2000
5	Progesterone Receptors (Progesterone Receptor)IBA 07/2015 - 03/2000
4	Messenger RNA (mRNA)IBA 04/2019 - 07/2001
3	AnthracyclinesIBA 07/2011 - 07/2001
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2006 - 03/2000
3	Fluorouracil (Carac)FDA LinkGeneric 04/2006 - 03/2000
2	PlatinumIBA 01/2014 - 07/2011
2	Alkylating AgentsIBA 07/2011 - 04/2006
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2011 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 04/2011
2	Epirubicin (Ellence)FDA LinkGeneric 04/2006 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 04/2004 - 03/2000
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Phenobarbital (Luminal)FDA Link 04/2019
1	Circulating Tumor DNAIBA 12/2017
1	Calcibiotic Root Canal SealerIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Hormones (Hormone)IBA 07/2015
1	HLA-G Antigens (HLA G)IBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Estrogen Receptor alphaIBA 12/2013
1	human ERBB2 proteinIBA 12/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2011
1	Histones (Histone)IBA 12/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2009
1	Histone DemethylasesIBA 12/2009
1	Lysine (L-Lysine)FDA Link 12/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2008
1	Androgen Receptors (Androgen Receptor)IBA 01/2008
1	Cadherins (E-Cadherin)IBA 01/2008
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2008
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2008
1	Keratins (Keratin)IBA 01/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2006
1	Tamoxifen FDA LinkGeneric 04/2006
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 04/2006
1	Carboplatin (JM8)FDA LinkGeneric 04/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2004
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2001
1	Epidermal Growth Factor (EGF)IBA 01/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2000

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 04/2019 - 03/2000
6	Therapeutics 08/2012 - 03/2000
4	Neoadjuvant Therapy 04/2011 - 05/2002
3	Radiotherapy 04/2006 - 04/2001
2	Adjuvant Chemotherapy 04/2010 - 11/2006
1	Ovariectomy (Oophorectomy) 04/2004
1	Salpingo-oophorectomy 04/2004
1	Induction Chemotherapy 05/2002